Welcome to Nawal Bahia El Idrissi, Director Strategy and Partnerships at Hid New West Health & Innovation District (HID) is pleased to announce a strengthening...

New West Health & Innovation District (HID) welcomes OLVG Lab BV!
OLVG Lab is focussing on three laboratory disciplines: Clinical chemistry, medical microbiology and pathology all in one organisation.

Sanquin Health Solutions sells Sanquin Reagents to Dutch investor Gilde Healthcare
Sanquin Health Solutions (SHS) is selling its reagents branch to the Dutch Gilde Healthcare, a specialized investment company in the healthcare sector.

The Plantijn city district is rising up around the Health & Innovation District
Cooperation partners Sanquin, the Antoni van Leeuwenhoek, Cordaan and Centrum voor Zorg Slotervaart have joined forces to turn De Plantijn in Amsterdam Nieuw-West into an innovative city neighborhood that will add even more value to the city. A place where care, research, living and education effortlessly go hand in hand. The Plantijn is one of the six districts of the future city district Schinkelkwartier.

Utopian ambitions for the blood bank of the future
Sanquin has come a long way since 1998, when the Dutch Blood Supply Act authorised it to manage the country’s need for blood and blood products as the only organisation in the Netherlands. Alongside meeting the responsibilities of a national blood bank for decades, Sanquin has steadily gone the extra mile when it comes to tackling challenges in haematology, immunology and oncology.

Health & Innovation District welcomes Mitsui Chemicals, Inc. as new resident
As of May 2022, the Japanese multinational Mitsui Chemicals, Inc. is the newest resident of the Health & Innovation District (Hid) around Sanquin's head office. At the Hid, start-ups and scale-ups, the business community and knowledge institutions work together to translate scientific research into practical applications, making healthcare better and more affordable worldwide.

New resident in the Health & Innovation District: GGD Amsterdam
A department of the Public Health Service of Amsterdam (GGD) regional laboratory is the newest Health & Innovation District (Hid) partner. A team of around six health service staff have settled into an inspiring new workplace taking advantage of the facilities offered on our campus.

New state-of-the-art laboratory facilities available at Sanquin in October 2022
Sanquin is currently developing the Health & Innovation District (Hid) around its existing headquarters on Plesmanlaan in Amsterdam. The Hid is home to a mix of large and small businesses active in the fields of transfusion medicine, oncology, immunology, and haematology. Together, they work to develop real-world applications for scientific research, making healthcare better and more affordable for people around the world.

Building Bridges for better Healthcare
Building Bridges for better Healthcare - New West Health & Innovation District (HID) has been a magnet for talented researchers, innovators and healthcare professionals for years. Our direct neighbour, Slotervaart, is a place where care and people will come together.

Frame attends congresses in Spring 2022
Frame Therapeutics’ Chief Scientific Officer Wigard Kloosterman will be speaking at different in person scientific conferences the upcoming months. From 26 – 28 April 2022 the 5th Neoantigen Summit Europe takes place in Amsterdam. This summit is dedicated to the robust prediction, identification, and validation of neoantigens to create truly individualized cancer therapeutics.

Sanquin Health Solutions and Catalyze enter into a strategic partnership to boost Sanquin’s innovation projects.
Amsterdam, December 8th, 2021 – Today, Sanquin Health Solutions (SHS) and Catalyze announce a new partnership to support the development of the New West Health & Innovation District (Hid), and support the innovation power of Sanquin and the partners based at its Amsterdam campus.

Prothya Biosolutions’ ‘panacea’ is saving lives
Human plasma is an amazing substance; it contains thousands of proteins that are essential for our bodies to function. For people who are deficient in one or more of these proteins, donor plasma can be a real lifesaver. One of Hid’s earliest residents, Prothya Biosolutions, produces plasma-derived medications in close cooperation with a number of Sanquin units.

BISC Global expands its Online Pipeline Platform (OP² ™)
“More and more data are being generated and faster than ever before, which has led to data analysis becoming a significant bottleneck in molecular biology research. With the expansion of OP², we want to continue helping researchers remove this hurdle,” said Jan Ghyssaert, COO at BISC Global.

Sanquin Academy – the connecting factor in the Hid
The Sanquin Academy was launched in 2021 as an independent business unit, located in Amsterdam’s New West Health & Innovation District (HID). In this interview, founder Anouk Wagenaar talks about the goals and potential of the Sanquin Academy, as well as her motivation and ambitions for the Academy.

More Hid coffee moments to come, after first edition yesterday
The library (next to Galerie Joghem) has been converted into a pleasant place for both Hid residents and Sanquiners. You can meet here informally or work in a nice shared space. The space is accessible to everyone all day long.

Half a million subsidy for expansion of laboratory and office space at Hid
From 2022, the New West Health & Innovation District (Hid) in Amsterdam will provide new laboratory and office space for companies in transfusion medicine, immunology, hematology and oncology. The need for office and lab space for these types of companies is great.

Hid resident BISC Global receives grant for further development of analysis software for immune repertoire
Hid residents talk about their projects and research results. BISC Global is a resident of the Hid. They recently received a large grant to further develop their Immune Repertory Analysis Software.

Extraordinary developments: Blood grown to order
Blood made to order, grown from stem cells: it might sound like science fiction, but for research group leader Emile van den Akker, it’s part of his daily work schedule. His Haematopoiesis research group at Sanquin Research is exploring ways of generating blood tailored to patients for whom it is difficult to find suitable donor blood. The research group is supported by a prestigious fund from ZonMw.

Come and work in the New West Health & Innovation District –in 2022!
The New West Health & Innovation District was officially launched in April 2021, with new residents, events, programmes and an academy. Ector Hoogstad Architecten has designed a master plan focused on creating an open and vibrant district that offers genuine opportunities for innovation. From 2023, the first phase of the master plan will be built.

Innovative cancer immunotherapies start-up
Hid tenant Frame Therapeutics develops on a novel cancer treatment based on personalised immunotherapies. The young start-up is like a duck takes to water on the Hid campus, not least because of the presence of Sanquin’s sophisticated laboratories.

"Sanquin is a fantastic partner to work with"
Our immune system is a wonderful thing: it consists of various defence mechanisms that keep out bacteria, viruses and other molecules foreign to the body. At Sanquin Research, located at the New West Health & Innovation District (Hid), a large group of scientists are intensively researching the immune system in order to unravel all its secrets.

Collaboration Sanquinnovate and Thuja
Sanquinnovate is Sanquin’s technology valorization and business development arm, creating new value-adding therapeutics and diagnostics to tackle challenges in the fields of hematology, immunology and oncology. Thuja is a venture capital fund manager investing in early stage life sciences innovations with high healthcare impact potential.

Sanquin and OLVG join forces in Amsterdam National Laboratory Centre on Hid site
Sanquin Diagnostics and OLVG Lab want to join forces in a large-scale regional laboratory that the government and the people can quickly rely on in the event of future virus crises.

Sanquin and OLVG join forces in Amsterdam National Laboratory Centre on Hid site
Sanquin Diagnostics and OLVG Lab want to join forces in a large-scale regional laboratory that the government and the people can quickly rely on in the event of future virus crises.

New West Health & Innovation District launched in Amsterdam
This week, the New West Health & Innovation District (Hid) in Amsterdam is launched. On this knowledge-intensive square kilometer in Amsterdam New-West, Sanquin is creating a campus that will house international scientists, start-ups and scale-ups and established companies in the field of oncology, immunology and hematology.

Rare coagulation diseases
Sanquin is working with the Netherlands Institute for Neuro Science and the Amsterdam-based start-up SanaGen on the development of gene therapy for the effective treatment of these diseases.

Working in the post-corona era
What are work environments like in the post-corona era? Architect Joost Ector: "Where people come together, ideas are born. A campus stimulates precisely this casual meeting, this informal exchange. "

Antibodies for treatment COVID-19
Hid resident Prothya Biosolutions released the first batch in October 2020. In only three months, the convalescent plasma (with antibodies against COVID-19) collected from ex-corona patients was tested and processed.

International investors for Prothya Biosolutions
A group of international investors invests heavily in Prothya Biosolutions and its associated company Plasma Industries Belgium (PIBe). This will make growth and further market expansion possible.

Iron storage
Blood donors who get more iron from meat or fish (heme iron) may be better capable of maintaining their iron storage, according to Tiffany Timmer, researcher at Sanquin Research.